Foresite Labs is a company focused on healthcare innovation, providing an incubation platform that aims to dismantle barriers to innovation in the life sciences sector.

Foresite Labs

Foresite Labs incubates companies that will address some of our greatest unmet medical needs. Their experienced team of scientists, engineers, and operators believes that the tools of data science, when applied with scientific rigor, will greatly accelerate scientific discovery and the development of new products and services that benefit patients. Through its incubation platform, Foresite Labs is dismantling the barriers faced by visionary entrepreneurs and their companies as they seek to re-invent healthcare. 

Foresite Labs Values
Truth over progression: We follow the science, pursuing ideas that are grounded in data and abandoning them when not supported by the evidence.

Take good risks: Our culture values informed risk-taking: good decisions are celebrated even when they result in bad outcomes. Everyone feels safe to contribute ideas and to learn from failure.

Single accountable person: The project team lead is accountable for all decisions and for maintaining transparency and information flow within the team; we trust the project teams. The Review Committee unlocks capital and sets directions.

Simplicity and Focus: “Companies die from indigestion, not starvation” (Bill Hewlett) We will focus on a few ideas aggressively and minimize all other distractions. Everyone will have a few key goals that have measurable outcomes.

Respect and Community: Our employees are our greatest asset; everyone invests in creating an environment of collaboration and respect. We support their careers and career development whether they stay, go to a Labs company, or end up somewhere else.

Last week was quite a week! Congratulations to Martin Babler & the team at Alumis on their IPO. Alumis was incubated by Foresite Labs; the company is developing two Tyrosine Kinase 2 inhibitor product candidates for patients living with immune-mediated diseases who need alternatives to existing treatments. This achievement represents years of work from the therapeutics team at Foresite Capital and the incubation team at Foresite Labs. Congrats to all!

I have an open position on my team for an experienced statistical and translational geneticist with a desire to apply his/her skills to biotech incubation. Want to learn about new venture creation and work with a team experienced in generating insights that can be used to improve patient lives? Let’s talk!

Our CEO Vik Bajaj is at HLTH Europe and will be speaking at the Touch Stage at 12:20 PM CEST for the panel discussion “Square peg, square hole - Unleashing the potential of genomics and personalized therapies”. Join him and industry experts Jason C. Foster, Dana Mendenhall, Benjamin Zaniello, MD MPH w/ moderator Rabab Nasrallah, PhD to learn about the potential that new therapies will have on the healthcare system as we know it. 

More about HLTH Europe here: https://europe.hlth.com/

Great progress at our incubated company Alumis. Congrats to the team on this progress.

News today from Foresite Labs' company, Alumis, which uses a precision medicine approach in its aim to transform the lives of patients with immune-mediated diseases. #psoriasis

Former Foresite Labs Fellow and current associate Chase Kelley recently sat down with Scott McIsaac to discuss his experiences participating in the joint Foresite Capital & Foresite Labs Fellows program. Check it out at the link below. We are now accepting applications for our upcoming cohort: https://lnkd.in/gJuaCbPR

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 7:36 AM	f539401c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 19, 2024 3:00 AM	75a2e915
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 18, 2024 7:36 AM	12350c1b
translate crunchbase fundingrounds	general
peers	general	Jul 18, 2024 7:36 AM	ed8d85df
news basic	general	Jul 18, 2024 7:36 AM	d0744e79
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

FORE

COM:FORESITELABS

Foresite Labs